• Collaborators Overview

Partnership Opportunities

iPierian plans to develop partnerships with pharmaceutical companies to further expand into larger disease areas, including cardiovascular and metabolic diseases.

For inquiries related to our business please contact:  BusinessDevelopment@ipierian.com

Current Collaborations

	Johns Hopkins Medicine iPierian is collaborating with Dr. Jeffrey Rothstein of the Johns Hopkins University School of Medicine on $3.7 Million NIH Grand Opportunities Grant in the area of amyotrophic lateral sclerosis (ALS).
	University of Cologne iPierian is collaborating with Dr. Brunhilde Wirth of the Institute of Human Genetics at the University of Cologne in order to build cell-based drug discovery models for spinal muscular atrophy (SMA).
	Gladstone Institute iPierian has a collaboration with The Gladstone Institute of Cardiovascular Disease and Dr. Deepak Srivastava, the institute’s director, in the area of calcific aortic valve disease (CAVD).